SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Appiphany Technologies Holdings Corp (OTCMKTS:APHD) opened at 0.0135 and hit a high of 0.465 to register over 3000 percent gains. The company today announced that it has secured an annual brand protection contract with TOMS Shoes, one of North America’s largest footwear manufacturers. TOMS’s have been testing Appiphany’s Watchdog online brand protection technology platform since March. For those who are unaware of TOMS, TOMS have been leading the way in their “Gift of Sight, Gift of Birth, Gift of Shoes and Gift of Water programs worldwide. Hopefully, this new contract will cause a positive effect on the not so impressive balance sheet of APHD.  Here is the reality:

As per the company’s last 10-Q report APHD, currently APHD has $4 in cash, total assets of $75 with total liabilities of $262K USD. Interestingly, the revenues for the three months ending Oct. 31, 2013 was $199. Earlier, the company had announced that that it has secured shareholder and board approval for a name change to IP Risk Control when approved by SEC and FINRA.

APHD

Earlier, the company had announced that it has hired Deborah Greaves, an Intellectual Property attorney specializing in the representation of fashion and consumer brands at Ezra Brutzkus Gubner LLP, Los Angeles. APHD also appointed Wayne Edwards as an advisor. Wayne is a founding member and past Chairman of CACN i(Canadian Anti-Counterfeiting Network), a coalition of individuals, companies, firms and associations united in the fight against product counterfeiting and copyright piracy in Canada and internationally –